Extended Follow-up of Microbiome Therapeutic SER-109 for Recurrent Clostridioides difficile Infection-Reply.
JAMA
; 329(12): 1033-1034, 2023 03 28.
Article
in En
| MEDLINE
| ID: mdl-36976280
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Clostridioides difficile
/
Clostridium Infections
/
Probiotics
/
Gastrointestinal Microbiome
Type of study:
Observational_studies
/
Prognostic_studies
Language:
En
Journal:
JAMA
Year:
2023
Document type:
Article
Country of publication:
Estados Unidos